Evidence map›Paper›PMID 41125585›Full record

ArticleBlood cancer journal2025

Efficacy assessment following shortened venetoclax exposure in AML patients treated with venetoclax plus hypomethylating agents: a real-world, multicentric study.

Sonja Wurm, Jennifer M Moritz, Verena Petzer, Dominik Wolf, Karoline V Gleixner, Wolfgang R Sperr, Christina Groiss, Sigrid Machherndl-Spandl, Gregor Eisenwort, Elisabeth Koller and 10 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors.

Sonja WurmDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-7540-737X
Jennifer M MoritzDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-5574-6692
Verena PetzerDepartment of Internal Medicine V, Haematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck (MUI), Innsbruck, Austria.ORCID http://orcid.org/0000-0002-9205-1440
Dominik WolfDepartment of Internal Medicine V, Haematology and Oncology, Comprehensive Cancer Center Innsbruck (CCCI) and Tyrolean Cancer Research Institute (TKFI), Medical University of Innsbruck (MUI), Innsbruck, Austria.ORCID http://orcid.org/0000-0002-4761-075X
Karoline V GleixnerDepartment of Internal Medicine I, Division of Hematology and Hemostaseology Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-5753-0203
Wolfgang R SperrDepartment of Internal Medicine I, Division of Hematology and Hemostaseology Medical University of Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-3288-8027
Christina GroissDivision of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz Elisabethinen, Linz, Austria.ORCID http://orcid.org/0009-0008-9096-0502
Sigrid Machherndl-SpandlDivision of Hematology with Stem Cell Transplantation, Hemostaseology and Medical Oncology, Department of Internal Medicine I, Ordensklinikum Linz Elisabethinen, Linz, Austria.ORCID http://orcid.org/0009-0007-1247-7948
Gregor EisenwortThird Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0003-2735-4645
Elisabeth KollerThird Medical Department for Hematology and Oncology, Hanusch Hospital Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0002-9912-0461
Johannes SchoecheDepartment of Medicine I, Center for Oncology and Hematology, Clinic Ottakring, Vienna, Austria.ORCID http://orcid.org/0000-0002-4740-5166
Clemens PetraschDepartment of Medicine I, Center for Oncology and Hematology, Clinic Ottakring, Vienna, Austria.ORCID http://orcid.org/0000-0001-5009-5579
Josef SingerKarl Landsteiner University of Health Sciences, Krems, Austria.ORCID http://orcid.org/0000-0002-8701-2412
Daniel M MayerDepartment of Internal Medicine I, Hospital of the Brothers of St. John of God, Graz, Austria.
Gudrun PregartnerInstitute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-9899-0502
Annkristin HeineDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-5298-9880
Albert WölflerDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0002-3112-9857
Heinz SillDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0003-0993-4371
Andreas ReinischDivision of Hematology, Medical University of Graz, Graz, Austria.ORCID http://orcid.org/0000-0001-9333-7689
Armin ZebischDivision of Hematology, Medical University of Graz, Graz, Austria. armin.zebisch@medunigraz.at.ORCID http://orcid.org/0000-0002-4861-7021

Funding

Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) Grant-DOI 10.55776/P36672Austrian Science Fund (Fonds zur Förderung der Wissenschaftlichen Forschung) Grant-DOI 10.55776/PAT1753824
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41125585
PMCPMC12546751

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.